tirzepatide clinical trial enrollment on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 PDF) Tirzepatide for the treatment
Description
Frequency: one subcutaneous injection each week
These medications should only be used under the supervision of a licensed healthcare provider
Think of it like stretching before exercise
Going from 10 mg to 15 mg roughly doubles the vomiting rate for about one extra percentage point of weight loss
Take 20 or 40 mg 2 times per day for up to 12 weeks
